906673-24-3 Usage
Description
Different sources of media describe the Description of 906673-24-3 differently. You can refer to the following data:
1. Crisaborole is a phosphodiesterase-
4 (PDE4) inhibitor that was approved by the USFDA for
the treatment of mild to moderate atopic dermatitis (AD) in
patients aged two years and older. The drug, which was
developed by Anacor Pharmaceuticals and later acquired and
marketed by Pfizer, is delivered as a 2% ointment, which is applied topically. The unique employment of boron within
the chemical structure of the drug is designed to enable
selective engagement of PDE4 (an enzyme involved in the
conversion of cAMP into AMP, which signals for downstream
inflammatory events), effective penetration of the drug through
human skin, and rapid clearance to limit systemic circulation.
2. AN2728 is a boron-based, topical anti-inflammatory agent that inhibits phosphodiesterase 4 (PDE4; IC50 = 0.11 μM). It is less potent against PDE1A, PDE3A, and PDE7A (IC50s = 6.12, 6.41, and 0.73 μM, respectively). AN2728 suppresses the release of the proinflammatory cytokines TNF-α, IL-2, INF-γ, IL-5, and IL-10 with IC50 values of 0.50, 0.59, 0.72, 2.25, and 2.58 μM, respectively.
Uses
A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release. 5-?(4-?Cyanophenoxy)?-?2,?3-?dihydro-?1-?hydroxy-?2,?1-?benzoxaborole (AN2728) showed potent activity both in vitro and in vivo. AN2728 is being studied as an anti-inflammatory agent.
Biochem/physiol Actions
Crisaborole is a non-steroidal anti-inflammatory phosphodiesterase 4 (PDE4) inhibitor. Crisaborole has an IC50 value of 490 nM for PDE4 with similar IC50 values for release of cytokines TNF-α, IL-2, and IFN-γ, and shows little inhibition against other PDE isozymes. Crisaborole has been approved as a topical treatment for atopic dermatitis.
Synthesis
Several disclosures describing synthetic approaches to
ethereal boron-containing anti-inflammatory compounds have
been published by Anacor. Commercially available bromobenzaldehyde
134 was protected as the corresponding acetal upon
subjection to warm ethylene glycol in the presence of catalytic
p-toluenesulfonic acid. This was followed by nucleophilic
aromatic substitution involving 4-fluorobenzonitrile and subsequent
acetal deprotection to furnish diaryl ether 136.
Although multiple approaches to crisaborole have been
reported from this intermediate diaryl ether 136, the
published literature approach involves the following sequence:
reduction of the aldehyde with sodium borohydride followed
by THP protection to furnish bromobenzene 137, which then
underwent lithium-halogen exchange prior to quenching with
triisopropyl borate and acidification to arrive at crisaborole
(XIII). Alternatively, patents from Anacor describe a general
approach employing a Miyaura coupling of 136, enabling the
installation of the corresponding pincacol borane, which could
then be exposed to reduction conditions using sodium
borohydride followed by boric acid wash, aqueous workup,
and lyophilization to furnish XIII.
Check Digit Verification of cas no
The CAS Registry Mumber 906673-24-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,6,7 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 906673-24:
(8*9)+(7*0)+(6*6)+(5*6)+(4*7)+(3*3)+(2*2)+(1*4)=183
183 % 10 = 3
So 906673-24-3 is a valid CAS Registry Number.
906673-24-3Relevant articles and documents
Preparation method of benzoxaborole compound
-
, (2021/07/17)
The invention discloses a preparation method of a benzoxaborole compound. The preparation method comprises the following steps: (1) reacting raw materials containing halogenated hydrocarbon and boric acid ester under an alkaline condition, acidifying and hydrolyzing to obtain an intermediate VI; and (2) reacting a raw material containing the intermediate VI with halogenated cyanophenyl to obtain the benzoxaborole compound. The raw materials are low in price, the preparation cost of the benzoxaborole compound is reduced, the steps of protection and de-protection of organic groups are not needed in the preparation process, the reaction process is simplified, and yield reduction caused by group protection is avoided; and meanwhile, the method is mild in reaction condition, low in equipment requirement and easy for large-scale industrial production.
Crisaborole intermediate, preparation method and application of crisaborole intermediate in preparation of crisaborole
-
, (2021/04/03)
The invention discloses a crisaborole intermediate, a preparation method and application of the crisaborole intermediate in preparation of crisaborole. The crisaborole intermediate has a structure asshown in a formula I in the specification. The preparation method comprises the following steps: carrying out Grignard reaction on a compound shown in a structural formula VI in an organic solvent A or carrying out exchange reaction with a metal Grignard reagent, and reacting with borate to obtain a compound shown in a structural formula V; reacting the obtained compound with the structural formula V with pinacol in an organic solvent B to obtain a compound with a structural formula IV; removing a protecting group from the compound shown in the structural formula IV in an organic solvent C toobtain a compound shown in a structural formula III; and carrying out a coupling reaction on the compound shown in the structural formula III and 4-halogenated cyanophenyl shown in the structural formula II in an organic solvent D under an alkaline condition to obtain the crisaborole intermediate shown in the structural formula I. The method effectively solves the problems of high production costand low product purity, and is suitable for industrial large-scale production.
METHOD FOR PREPARING CRISABOROLE
-
, (2021/02/26)
The invention relates to a method for preparing Crisaborole of Formula I, comprising using m-methylphenol as the starting material to obtain a target product through a five-step reaction. The starting materials and the raw materials used in each step of the method according to the present invention are cheap and easy to obtain, and the process is simple. The reaction of introducing boron atoms into the benzene ring to form an oxygen boron heterocycle is novel, with high yield and mild conditions, and is suitable for industrial production.